AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 107 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,036,306 | -50.7% | 475,910 | -14.4% | 0.00% | 0.0% |
| Q2 2023 | $6,164,211 | -60.4% | 555,835 | -45.2% | 0.00% | -66.7% |
| Q1 2023 | $15,556,842 | -37.3% | 1,013,475 | -9.4% | 0.00% | -50.0% |
| Q4 2022 | $24,825,884 | +145.6% | 1,118,787 | +80.8% | 0.01% | +200.0% |
| Q3 2022 | $10,107,000 | +279.5% | 618,900 | +237.7% | 0.00% | +100.0% |
| Q2 2022 | $2,663,000 | +18.3% | 183,283 | +50.4% | 0.00% | – |
| Q1 2022 | $2,251,000 | -14.1% | 121,892 | +10.6% | 0.00% | -100.0% |
| Q4 2021 | $2,620,000 | -69.1% | 110,233 | -68.0% | 0.00% | -50.0% |
| Q3 2021 | $8,484,000 | +77.1% | 344,479 | +77.7% | 0.00% | +100.0% |
| Q2 2021 | $4,791,000 | -39.8% | 193,861 | -46.9% | 0.00% | -50.0% |
| Q1 2021 | $7,962,000 | +39.2% | 365,045 | +62.9% | 0.00% | +100.0% |
| Q4 2020 | $5,720,000 | +101.0% | 224,144 | +121.7% | 0.00% | 0.0% |
| Q3 2020 | $2,846,000 | -34.2% | 101,118 | -33.9% | 0.00% | 0.0% |
| Q2 2020 | $4,322,000 | – | 152,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
| 5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
| Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
| EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
| Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
| RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
| Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
| Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
| Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |